LAS VEGAS -- Skinvisible, Inc. announces that it has signed a distribution agreement with Canadian-based Clara Laboratories Ltd. granting them the right to distribute, market and sell its patented Antimicrobial Hand Sanitizer lotion and spray formulation through established sub-distributors in China, Singapore, Hong Kong and Macau.
Skinvisible has shipped an initial order of 19 55-gallon drums of the Antimicrobial Hand Sanitizer formulation for the Honk Kong market. Skinvisible expects to ship product both in bulk drums and pre-packaged in order to meet a strong and growing demand for its proprietary formulation within the Asian marketplace. Clara Laboratories has a mandate to represent and promote North American medical technologies within the Asian marketplace and reciprocally represent Asian technologies within North America.
Proven advantages of the Skinvisible formulation include its demonstrated ability to adhere to the skin, forming a protective bond, resisting both wash-off and perspiration while holding the active ingredient Triclosan on the skin for extended periods of time. Independent studies show that the active agent stays on the skin for up to 4 hours per application, maintaining its effectiveness even with frequent hand washings, providing a continuous kill of pathogens tested during that time. Skinvisible's proprietary formulation is alcohol-free, offering distinct advantages over alcohol-based gel sanitizers that typically provide instant protection but offer no long-term persistence, wash-off, and require continuous reapplication, sometimes causing adverse skin reactions.
"Although it is proven to be effective on its own, we specifically designed our sanitizer formulation to be a complementary adjunct to hand washing rather than a replacement," emphasizes Skinvisible's chemist, Dr. James Roszell. "What sets our product apart is not only its ability to bond to the skin and remain effective for extended periods, but also the simultaneous benefit of protecting the skin against the rigors of even frequent hand-washing such as that required to meet medical and food service protocols."
Source: Skinvisible, Inc.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.